GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...

Young International Scientists Say: Seeking Knowledge and Opportunities in China

Young International Scientists Say: Seeking Knowledge and Opportunities in China

BEIJING, Nov. 25, 2024 /PRNewswire/ -- A news report from Science and Technology Daily: Osama Abdalla Abdelshafy Mohamed. (COURTESY PHOTO) Seek knowledge even if you have to go as far as China, as an Arabic old saying goes. For Osama Abdalla...

/C O R R E C T I O N -- Sky Labs/

/C O R R E C T I O N -- Sky Labs/

In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued 24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the...

State Grid Changji Power Supply Company: First Domestic Application of Temporary Voltage Drop Management Device Deployed in Changji

State Grid Changji Power Supply Company: First Domestic Application of Temporary Voltage Drop Management Device Deployed in Changji

CHANGJI, China, Nov. 20, 2024 /PRNewswire/ -- On November 18, the State Grid Changji Power Supply Company successfully deployed an innovative project, "Research on Key Technologies for Managing Temporary Voltage Drops in Distribution Networks and...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • menu
    menu